Haematology and Acute Myeloid Leukemia

Clinical research activity is centred on acute myeloid leukemia, with attention to relapsed/refractory disease and NPM1-mutated AML. The sponsor’s trial portfolio reflects a focused interest in treatment-resistant myeloid malignancies managed within a hospital-based setting.

• Acute Myeloid Leukemia
• Relapsed/Refractory AML
• NPM1-mutated Leukemia

Research in this area is directed toward assessing antileukemic activity alongside safety and tolerability in patients with difficult-to-treat hematologic cancer.